The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Minocycline Nanocrystals: A New Approach for Treating Acne with Reduced Systemic Side Effects
Abstract
Background/Objectives: Acne vulgaris is a chronic skin infection characterized by high sebum secretion, keratosis around hair follicles, inflammation, and imbalance in androgen levels. Acne vulgaris causes permanent scars or skin pigmentation in cases of improper treatment. Oral or topical isotretinoin, contraceptives, and antibiotics are used to treat acne. Minocycline is one of the widely used tetracyclines for this purpose; it inhibits the synthesis of proteins in bacterial ribosomes. Commonly, minocycline is prescribed daily for several months for acne vulgaris. Systemic minocycline is highly distributed into body fluids, and it is associated with several side effects and antibiotic resistance. Additionally, minocycline is highly metabolized in the liver, leading to reduced bioavailability upon systemic delivery. This study aims to develop and characterize minocycline nanocrystals for targeted skin delivery and evaluate their antimicrobial efficacy in treating acne vulgaris. Methods: Minocycline nanocrystals were synthesized using milling or solvent evaporation techniques. Nanocrystals were characterized in terms of particle size, particle distribution index (PDI), zeta potential, and morphology. The antibacterial efficacy against Propionibacterium acne, Staphylococcus aureus, and Staphylococcus epidermidis was evaluated using a minimum inhibitory concentration assay (MIC) and agar well diffusion test in comparison to coarse minocycline. Results: Minocycline nanocrystals had a particle size of 147.4 ± 7.8 nm and 0.27 ± 0.017 of PDI. The nanocrystals exhibited a loading efficiency of 86.19 ± 16.7%. Antimicrobial testing showed no significant difference in activity between minocycline and its nanoparticle formulation. In terms of skin deposition, the nanocrystals were able to deliver minocycline topically to rat skin significantly more than free minocycline. The nanocrystal solution deposited 554.56 ± 24.13 μg of minocycline into rat skin, whereas free minocycline solution deposited 373.99 ± 23.32 μg. Conclusions: Minocycline nanocrystals represent a promising strategy for targeted skin delivery in the treatment of acne vulgaris, potentially reducing systemic side effects and antibiotic resistance and improving patient outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This finding is in parallel of previously reported studies demonstrating the high potential of MNs to be successfully inserted into skin in vivo [37,38].”
From Formulation and Characterization of PLGA Minocycline Microneedles for Enhanced Skin Deposition and Antibacterial Activity in Acne Treatment (2025) · cites this paper as [37]
In the citing paper
“This enhanced effect is attributed to a synergistic mechanism, in which minocycline inhibits bacterial protein synthesis by binding to the 30 S ribosomal subunit [39], while ZIF-8 induces membrane destabilization and oxidative stress through zinc ion release, thereby amplifying bacterial cell damage [40] (Fig. 4B and E).”
From Dissolvable silk microneedles delivering minocycline-loaded ZIF-8 nanoparticles for targeted modulation of sebocyte metabolism and improved acne therapy (2026) · cites this paper as [39]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods for in vitro evaluating antimicrobial activity: A review
Balouiri, M., Sadiki, M., & Ibnsouda, S. K. (2016) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2015.11.005 · Cited by 8,044
Research works printed but not linked: 35
- Chen, 2022, Magnitude and temporal trend of acne vulgaris burden in 204 countries and territories from 1990 to 2019: An analysis from the Global Burden of Disease Study 2019, Br. J. Dermatol., 186, 673, 10.1111/bjd.20882 · DOI
- Zhang, L., Cai, Y., Li, L., Hu, J., Jia, C., Kuang, X., Zhou, Y., Lan, Z., Liu, C., and Jiang, F. (2025). Analysis of global trends and hotspots of skin microbiome in acne: A bibliometric perspective. BioData Min., 18. · DOI
- Haider, 2004, Treatment of acne vulgaris, JAMA, 292, 726, 10.1001/jama.292.6.726 · DOI · Paper page
- Martins, A.M., Marto, J.M., Johnson, J.L., and Graber, E.M. (2021). A review of systemic minocycline side effects and topical minocycline as a safer alternative for treating acne and rosacea. Antibiotics, 10. · DOI
- Panizzutti, B., Skvarc, D., Lin, S., Croce, S., Meehan, A., Bortolasci, C.C., Marx, W., Walker, A.J., Hasebe, K., and Kavanagh, B.E. (2023). Minocycline as treatment for psychiatric and neurological conditions: A systematic review and meta-analysis. Int. J. Mol. Sci., 24. · DOI
- Dominic, 2021, Adverse reactions induced by minocycline: A review of literature, Curr. Drug Saf., 16, 309, 10.2174/1574886316666210120090446 · doi:10.2174/1574886316666210120090446
- Prausnitz, 2008, Transdermal drug delivery, Nat. Biotechnol., 26, 1261, 10.1038/nbt.1504 · DOI · Paper page
- Alkrad, 2022, Microemulsions as nanocarriers for oral and transdermal administration of enoxaparin, J. Drug Deliv. Sci. Technol., 70, 103248, 10.1016/j.jddst.2022.103248 · DOI
- Abu Ershaid, J.M., Zhang, H., Tayyem, M., Sabri, A.H., Donnelly, R.F., and Vora, L.K. (2024). Sodium Alginate Microneedles Loaded with Vancomycin for Skin Infections. J. Funct. Biomater., 15. · DOI · Paper page
- Li, 2021, The solubility profile and dissolution thermodynamic properties of minocycline hydrochloride in some pure and mixed solvents at several temperatures, J. Chem. Thermodyn., 157, 106399, 10.1016/j.jct.2021.106399 · DOI
- Anjum, S., Ishaque, S., Fatima, H., Farooq, W., Hano, C., Abbasi, B.H., and Anjum, I. (2021). Emerging applications of nanotechnology in healthcare systems: Grand challenges and perspectives. Pharmaceuticals, 14. · DOI · Paper page
- Sabbagh, 2023, Transdermal delivery of catechin using dissolving poly (vinyl alcohol)-based microneedles: Effect of microneedle composition on drug release, ACS Appl. Polym. Mater., 5, 8919, 10.1021/acsapm.3c01293 · doi:10.1021/acsapm.3c01293
- Li, 2021, Antibacterial, hemostasis, adhesive, self-healing polysaccharides-based composite hydrogel wound dressing for the prevention and treatment of postoperative adhesion, Mater. Sci. Eng. C, 123, 111978, 10.1016/j.msec.2021.111978 · DOI
- Ghasemiyeh, 2022, Novel topical drug delivery systems in acne management: Molecular mechanisms and role of targeted delivery systems for better therapeutic outcomes, J. Drug Deliv. Sci. Technol., 74, 103595, 10.1016/j.jddst.2022.103595 · DOI
- El, 2014, Synthesis, characterization, controlled release, and antibacterial studies of a novel streptomycin chitosan magnetic nanoantibiotic, Int. J. Nanomed., 9, 549
- Liu, 2020, Highly stabilized nanocrystals delivering Ginkgolide B in protecting against the Parkinson’s disease, Int. J. Pharm., 577, 119053, 10.1016/j.ijpharm.2020.119053 · DOI
- El, 2014, Synthesis, characterization, and antimicrobial activity of an ampicillin-conjugated magnetic nanoantibiotic for medical applications, Int. J. Nanomed., 9, 3801
- Ershaid, 2024, Freeze-dried erythromycin nanocrystals: Preparation, characterisation, antimicrobial activity, and aerodynamic properties, Pharmacia, 71, 1, 10.3897/pharmacia.71.e127826 · DOI
- Verruck, 2023, The mechanism, biopolymers and active compounds for the production of nanoparticles by anti-solvent precipitation: A review, Food Res. Int., 168, 112728, 10.1016/j.foodres.2023.112728 · DOI
- Shackleford, 2003, Contribution of lymphatically transported testosterone undecanoate to the systemic exposure of testosterone after oral administration of two andriol formulations in conscious lymph duct-cannulated dogs, J. Pharmacol. Exp. Ther., 306, 925, 10.1124/jpet.103.052522 · DOI
- Xiang, H., Xu, S., Zhang, W., Li, Y., Zhou, Y., and Miao, X. (2023). Skin permeation of curcumin nanocrystals: Effect of particle size, delivery vehicles, and permeation enhancer. Colloids Surf. B Biointerfaces, 224. · DOI
- Durairaju, 2024, Synthesis, antiproliferative, antibacterial activity of acridone derivatives: Experimental and theoretical calculations, J. Mol. Struct., 1316, 138841, 10.1016/j.molstruc.2024.138841 · DOI
- Gao, 2008, Drug nanocrystals for the formulation of poorly soluble drugs and its application as a potential drug delivery system, J. Nanoparticle Res., 10, 845, 10.1007/s11051-008-9357-4 · DOI · Paper page
- Lead, 2006, Aquatic colloids and nanoparticles: Current knowledge and future trends, Environ. Chem., 3, 159, 10.1071/EN06025 · DOI · Paper page
- Junghanns, 2008, Nanocrystal technology, drug delivery and clinical applications, Int. J. Nanomed., 3, 295
- Giradkar, 2024, Nanocrystals: A Multifaceted Regimen for Dermatological Ailments, Part. Part. Syst. Charact., 41, 2300147, 10.1002/ppsc.202300147 · DOI
- Shah, 2017, Fabrication and evaluation of smart nanocrystals of artemisinin for antimalarial and antibacterial efficacy, Afr. J. Tradit. Complement. Altern. Med., 14, 251, 10.21010/ajtcam.v14i1.27 · DOI
- Li, 2021, Progress in the development of stabilization strategies for nanocrystal preparations, Drug Deliv., 28, 19, 10.1080/10717544.2020.1856224 · DOI · Paper page
- Abu Ershaid, J.M., Vora, L.K., Volpe-Zanutto, F., Sabri, A.H., Peng, K., Anjani, Q.K., McKenna, P.E., Ripolin, A., Larrañeta, E., and McCarthy, H.O. (2023). Microneedle array patches for sustained delivery of fluphenazine: A micron scale approach for the management of schizophrenia. Biomater. Adv., 153. · DOI · Paper page
- Singh, 2011, Investigation of preparation parameters of nanosuspension by top-down media milling to improve the dissolution of poorly water-soluble glyburide, Eur. J. Pharm. Biopharm., 78, 441, 10.1016/j.ejpb.2011.03.014 · doi:10.1016/j.ejpb.2011.03.014
- Shaarani, 2017, The Influence of pluronic F68 and F127 nanocarrier on physicochemical properties, in vitro release, and antiproliferative activity of thymoquinone drug, Pharmacogn. Res., 9, 12, 10.4103/0974-8490.199774 · DOI
- Cacua, 2019, Surfactant concentration and pH effects on the zeta potential values of alumina nanofluids to inspect stability, Colloids Surf. A Physicochem. Eng. Asp., 583, 123960, 10.1016/j.colsurfa.2019.123960 · DOI · Paper page
- Eleraky, N.E., Allam, A., Hassan, S.B., and Omar, M.M. (2020). Nanomedicine Fight against Antibacterial Resistance: An Overview of the Recent Pharmaceutical Innovations. Pharmaceutics, 12. · DOI · Paper page
- Dixit, 2025, Polymeric nanoparticles-based targeted delivery of drugs and bioactive compounds for arthritis management, Future Sci. OA, 11, 2467591, 10.1080/20565623.2025.2467591 · DOI
- Hazot, 2017, Topical oleaginous minocycline foam: Efficacious delivery into skin layers, J. Anal. Pharm. Res., 4, 00117
Cited by
Abu Ershaid, J. M., Abudoleh, S. M., Lafi, D. N., & Dahshan, N. A. (2025) · Polymers · doi:10.3390/polym17212912 · Cited by 5
Self-citationYang, X., Ruan, D., Ye, F., Qiu, X., Li, S., Huang, L., Zouboulis, C. C., Mo, X., Jiang, X., & Ju, Q. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04221-8 · Cited by 4
Metadata
- Authors
- Abudoleh, S. M., Abu Ershaid, J. M., Lafi, D., Dahshan, N. A., Talhouni, A., & Abuirmeileh, A.
- Venue
- Pharmaceutics
- Publisher
- MDPI AG
- Published
- 2025-05-31
- Volume
- 17
- Issue
- 6
- Pages
- 727
- ISSN
- 1999-4923
- Cited by
- 8
- References
- 1
- Language
- en
- Funders
- Isra University (2023/2022/35-11)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Minocycline Nanocrystals: A New Approach for Treating Acne with Reduced Systemic Side Effects. https://app.cochat.ai/papers/10.3390/pharmaceutics17060727
- The paper
- Abudoleh, S. M., Abu Ershaid, J. M., Lafi, D., Dahshan, N. A., Talhouni, A., & Abuirmeileh, A. (2025). Minocycline Nanocrystals: A New Approach for Treating Acne with Reduced Systemic Side Effects. Pharmaceutics. https://doi.org/10.3390/pharmaceutics17060727
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.